Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000899243-19-015822

Options or other derivatives

  • Director acquired 21,155 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Phillips Gary M. Director 2019-06-04 Grant or award · Employee Stock Option (Right to Buy) +18,951 18,951 D
Phillips Gary M. Director 2019-06-04 Grant or award · Employee Stock Option (Right to Buy) +2,204 2,204 D
Loading xslF345X03/doc4.xml…